Whether TERT promoter mutations and variable RTL are indeed associated with poor overall survival (OS), as suggested by their association with clinicopathologic features of glioma patients, was subsequently investigated by univariate survival analysis. The gene discussed is TERT; the disease is central nervous system cancer.